1. Greece Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 67
Price: Single User License – US$2500
Greece Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Summary
Global Markets Direct’s new report, “Greece Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018” provides key market data on the Greece Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Greece Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi , LifeScan, Inc., Novo Nordisk
A/S , Eli Lilly and Company, Becton, Dickinson and Company and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Greece Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/195373-greece-diabetes-care-devices-investment-opportunities-analysis-
and-forecasts-to-2018.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Greece 8
3.1 Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Greece, Company Share (2010-2011) 13
4 Glucose Monitoring In Greece 15
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 15
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 19
4.2 Glucose Monitoring Overall Volume (2004-2018) 21
4.2.1 Blood Glucose Meters, Volume (2004-2018) 25
4.3 Glucose Monitoring Average Price (2004-2018) 27
4.4 Glucose Monitoring Distribution Share (2010-2011) 28
4.5 Glucose Monitoring, Greece, Company Share (2010-2011) 29
5 Insulin Delivery In Greece 31
5.1 Insulin Delivery Overall Revenue, (2004-2018) 31
5.1.1 Insulin Pens, Revenue (2004-2018) 35
5.1.2 Insulin Pumps, Revenue (2004-2018) 39
5.2 Insulin Delivery Overall Volume (2004-2018) 41
5.2.1 Insulin Pens, Volume (2004-2018) 45
5.2.2 Insulin Pumps, Volume (2004-2018) 49
5.3 Insulin Delivery Average Price (2004-2018) 51
5.4 Insulin Delivery Distribution Share (2010-2011) 52

3. 5.5 Insulin Delivery, Greece, Company Share (2010-2011) 53
6 Overview of Key Companies in Greece Diabetes Care Devices Market 55
6.1 F. Hoffmann-La Roche Ltd. 55
6.1.1 Company Overview 55
6.2 Sanofi 55
6.2.1 Company Overview 55
6.3 LifeScan, Inc. 56
6.3.1 Company Overview 56
6.4 Novo Nordisk A/S 56
6.4.1 Company Overview 56
6.5 Eli Lilly and Company 56
6.5.1 Company Overview 56
6.6 Bayer HealthCare AG 57
6.6.1 Company Overview 57
6.7 Abbott Laboratories 57
6.7.1 Company Overview 57
6.8 Becton, Dickinson and Company 58
6.8.1 Company Overview 58
6.9 Medtronic, Inc. 58
6.9.1 Company Overview 58
6.10 Animas Corporation 59
6.10.1 Company Overview 59
6.11 Terumo Corporation 59
6.11.1 Company Overview 59
6.12 Ypsomed Holding AG 59
6.12.1 Company Overview 59
6.13 Nipro Corporation 60
6.13.1 Company Overview 60
7 Appendix 61
7.1 Global Markets Direct Research Methodology 61
7.2 Definitions of Markets Covered in the Report 62
7.2.1 Diabetes Care Devices 62
7.3 Secondary Research 65
7.4 Primary Research 65
7.5 Models 66
7.6 Forecasts 66
7.7 Expert Panel Validation 66
7.8 Currency Conversion 67
7.9 Contact Us 67
7.10 Disclaimer 67
1.1 List of Tables

4. Table 1: Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018 8
Table 2: Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 10
Table 3: Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 12
Table 4: Diabetes Care Devices, Greece, Company Share by Revenue ($m), USD Constant,
2010-2011 14
Table 5: Glucose Monitoring, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 16
Table 6: Glucose Monitoring, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 18
Table 7: Blood Glucose Meters (Traditional Glucose Meters), Greece, Revenue ($m) USD
Constant, Historic, 2004-2011 19
Table 8: Blood Glucose Meters (Traditional Glucose Meters), Greece, Revenue ($m) USD
Constant, Forecast, 2011-2018 20
Table 9: Glucose Monitoring, Greece, Volume (Units) by Segment, Historic, 2004-2011 22
Table 10: Glucose Monitoring, Greece, Volume (Units) by Segment, Forecast, 2011-2018 24
Table 11: Blood Glucose Meters (Traditional Glucose Meters), Greece, Volume (Units), Historic,
2004-2011 25
Table 12: Blood Glucose Meters (Traditional Glucose Meters), Greece, Volume (Units), Forecast,
2011-2018 26
Table 13: Glucose Monitoring, Greece, Average Price ($), Historic, 2004-2011 27
Table 14: Glucose Monitoring, Greece, Average Price ($), Forecast, 2011-2018 27
Table 15: Glucose Monitoring, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 28
Table 16: Glucose Monitoring, Greece, Company Share by Revenue ($m), USD Constant, 2010-
2011 30
Table 17: Insulin Delivery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 32
Table 18: Insulin Delivery, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 34
Table 19: Insulin Pens, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 36
Table 20: Insulin Pens, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 38
Table 21: Insulin Pumps (Traditional Insulin Pumps), Greece, Revenue ($m) USD Constant,
Historic, 2004-2011 39
Table 22: Insulin Pumps (Traditional Insulin Pumps), Greece, Revenue ($m) USD Constant,
Forecast, 2011-2018 40
Table 23: Insulin Delivery, Greece, Volume (Units) by Segment, Historic, 2004-2011 42
Table 24: Insulin Delivery, Greece, Volume (Units) by Segment, Forecast, 2011-2018 44
Table 25: Insulin Pens, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011 46

5. Table 26: Insulin Pens, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018 48
Table 27: Insulin Pumps (Traditional Insulin Pumps), Greece, Volume (Units), Historic, 2004-2011
49
Table 28: Insulin Pumps (Traditional Insulin Pumps), Greece, Volume (Units), Forecast, 2011-
2018 50
Table 29: Insulin Delivery, Greece, Average Price ($), Historic, 2004-2011 51
Table 30: Insulin Delivery, Greece, Average Price ($), Forecast, 2011-2018 51
Table 31: Insulin Delivery, Greece, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 52
Table 32: Insulin Delivery, Greece, Company Share by Revenue ($m), USD Constant, 2010-2011
54
1.2 List of Figures
Figure 1: Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 9
Figure 3: Diabetes Care Devices, Greece, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 11
Figure 4: Diabetes Care Devices, Greece, Company Share (%), 2011 13
Figure 5: Glucose Monitoring, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 15
Figure 6: Glucose Monitoring, Greece, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 17
Figure 7: Blood Glucose Meters (Traditional Glucose Meters), Greece, Revenue ($m) USD
Constant, Historic, 2004-2011 19
Figure 8: Blood Glucose Meters (Traditional Glucose Meters), Greece, Revenue ($m) USD
Constant, Forecast, 2011-2018 20
Figure 9: Glucose Monitoring, Greece, Volume (Units) by Segment, Historic, 2004-2011 21
Figure 10: Glucose Monitoring, Greece, Volume (Units) by Segment, Forecast, 2011-2018 23
Figure 11: Blood Glucose Meters (Traditional Glucose Meters), Greece, Volume (Units), Historic,
2004-2011 25
Figure 12: Blood Glucose Meters (Traditional Glucose Meters), Greece, Volume (Units), Forecast,
2011-2018 26
Figure 13: Glucose Monitoring, Greece, Company Share (%), 2011 29
Figure 14: Insulin Delivery, Greece, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 31
Figure 15: Insulin Delivery, Greece, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 33
Figure 16: Insulin Pens, Greece, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 35
Figure 17: Insulin Pens, Greece, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 37

6. Figure 18: Insulin Pumps (Traditional Insulin Pumps), Greece, Revenue ($m) USD Constant,
Historic, 2004-2011 39
Figure 19: Insulin Pumps (Traditional Insulin Pumps), Greece, Revenue ($m) USD Constant,
Forecast, 2011-2018 40
Figure 20: Insulin Delivery, Greece, Volume (Units) by Segment, Historic, 2004-2011 41
Figure 21: Insulin Delivery, Greece, Volume (Units) by Segment, Forecast, 2011-2018 43
Figure 22: Insulin Pens, Greece, Volume (Units) by Sub-Segment, Historic, 2004-2011 45
Figure 23: Insulin Pens, Greece, Volume (Units) by Sub-Segment, Forecast, 2011-2018 47
Figure 24: Insulin Pumps (Traditional Insulin Pumps), Greece, Volume (Units), Historic, 2004-2011
49
Figure 25: Insulin Pumps (Traditional Insulin Pumps), Greece, Volume (Units), Forecast, 2011-
2018 50
Figure 26: Insulin Delivery, Greece, Company Share (%), 2011 53
Figure 27: Global Markets Direct Methodology 61
Contact: sales@reportsandreports.com for more information.